{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:57:08Z","timestamp":1789822628910,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/bf02931577","type":"journal-article","created":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T07:15:16Z","timestamp":1218266116000},"page":"359-369","source":"Crossref","is-referenced-by-count":30,"title":["Mode of action of microbial bioactive metabolites"],"prefix":"10.1007","volume":"51","author":[{"given":"V.","family":"B\u011bhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02931577_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/AAC.43.2.335","volume":"43","author":"J.R. Aeschimann","year":"1999","unstructured":"Aeschimann J.R., Dresswr L.D., Kaatz G.W., Rybak M.J.: Effects of NorA inhibitors onin vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains ofStaphylococcus aureus.Antimicrob.Agents Chemother. 43, 335\u2013340 (1999).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR2","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.071527498","volume":"98","author":"L. Belova","year":"2001","unstructured":"Belova L., Tenson T., Xiong L., Mcnichols P.M., Mankin A.S.: A novel site of antibiotic action in the ribosome interaction of evernimicin with the large ribosomal subunit.Proc.Nat.Acad.Sci.USA 98, 3726\u20133731 (2001).","journal-title":"Proc.Nat.Acad.Sci.USA"},{"key":"BF02931577_CR3","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1073\/pnas.130198797","volume":"97","author":"R.M. Bookchin","year":"2000","unstructured":"Bookchin R.M., Etzion Z., Sorette M., Mohandas N., Skepper J.N., Lew V.L.: Identification and characterization of a newly recognized population of high-Na+, low-K+, low-density sickle and normal red cells.Proc.Nat.Acad.Sci.USA 97, 8045\u20138050 (2000).","journal-title":"Proc.Nat.Acad.Sci.USA"},{"key":"BF02931577_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.15.6.747","volume":"15","author":"M.J. Brown","year":"1979","unstructured":"Brown M.J.: Mechanism and specificity of action of ribovirin.Antimicrob.Agents Chemother. 15, 747\u2013753 (1979).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","volume":"15","author":"R.W. Burg","year":"1979","unstructured":"Burg R.W., Miller B.M., Baker E.E., Birnbaum J., Currier S.A., Hartman R., Yu-Ling K., Monaglan R.L., Olson G., Putter I., Tunac J.B., Wellick H., Stampley E.O., Oiwa R., Omura S.: Avermectins, new family of potent anthelmintie agents: production organism and fermentation.Antimicrob.Agents Chemother. 15, 361\u2013367 (1979).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/B978-0-7506-9095-9.50026-5","volume-title":"Genetics and Biochemistry of Antibiotic Production","author":"J.S. Chiao","year":"1995","unstructured":"Chiao J.S., Yia T.H., Mei B.G., Jin Z.K., Gu W.L.: Rifamycin SV and related ansamycins. pp. 477\u2013478 in L.C. Vining, C. Stuttard (Eds):Genetics and Biochemistry of Antibiotic Production. Butterword-Heinemann, Boston 1995."},{"key":"BF02931577_CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I. Chopra","year":"2001","unstructured":"Chopra I., Roberts M.: Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.Microbiol.Mol.Biol.Rev. 65, 232\u2013260 (2001).","journal-title":"Microbiol.Mol.Biol.Rev."},{"key":"BF02931577_CR8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF02931557","volume":"49","author":"M. \u010ciko\u0161ov\u00e1","year":"2004","unstructured":"\u010ciko\u0161ov\u00e1 M., Blazsek M., Kubi\u0161 M., Gajdo\u0161\u00edkov\u00e1 J., Boro\u0161ov\u00e1 G.: Biotechnological preparation of the elaiophylin.Folia Microbiol. 49, 731\u2013736 (2004).","journal-title":"Folia Microbiol."},{"key":"BF02931577_CR9","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1073\/pnas.94.20.10594","volume":"94","author":"S. Dey","year":"1997","unstructured":"Dey S., Ramachandra M., Pastan I., Gattesman M.M., Ambudkar S.V.: Evidence for two nonidentical drug-interaction sites in the humanP-glycoprotein.Proc.Nat.Acad.Sci.USA 94, 10594\u201310599 (1997).","journal-title":"Proc.Nat.Acad.Sci.USA"},{"key":"BF02931577_CR10","first-page":"487","volume":"6","author":"J. Ehrlich","year":"1956","unstructured":"Ehrlich J., Cofey G.L., Fischer M.W., Hillegas A.B., Kohbeger D.I., Machamer H.E., Rightsel H.E., Roegner F.R.: 6-Diazo-5-oxo-l-norleucine, a new tumor inhibitory substance.Antibiot.Chemother. 6, 487\u2013496 (1956).","journal-title":"Antibiot.Chemother."},{"key":"BF02931577_CR11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/JB.180.2.388-394.1998","volume":"180","author":"M. Farutani","year":"1998","unstructured":"Farutani M., Iida T., Yamano S., Kamino K., Maruyama T.: Biochemical and genetic characterization of an FK506-sensitive peptidyl-prolylcis\u2014trans isomerase from a thermophilic archeon.Methanococcus thermolithotropicus. J.Bacteriol. 180, 388\u2013394 (1998).","journal-title":"Methanococcus thermolithotropicus. J.Bacteriol."},{"key":"BF02931577_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/AAC.47.1.283-291.2003","volume":"47","author":"Z. Feng","year":"2003","unstructured":"Feng Z., Barletta R.G.: Roles ofMycobacterium smegmatis d-alanine:d-alanine ligase andd-alanine racemase in mechanisms of action of and resistance to the peptidoglycan inhibitord-cycloserin.Antimicrob.Agents Chemother. 47, 283\u2013291 (2003).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/eji.1830190109","volume":"19","author":"M. Fukuzava","year":"1989","unstructured":"Fukuzava M., Shearer G.M.: Effect of cyclosporin A on T cell immunity. I. Dose-dependent suppression of different murine T-helper cell pathways.Eur.J.Immunol. 19, 49\u201356 (1989).","journal-title":"Eur.J.Immunol."},{"key":"BF02931577_CR14","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.45.10.2813-2819.2001","volume":"45","author":"M.C. Ganoza","year":"2001","unstructured":"Ganoza M.C., Kiel M.C.: A ribosomal ATPase is a target for hygromycin B inhibition onEschericia coli ribosomes.Antimicrob. Agents Chemother. 45, 2813\u20132819 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF02931577_CR15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","volume":"43","author":"R.E.W. Hancock","year":"1999","unstructured":"Hancock R.E.W., Chaple D.S.: Peptide antibiotics.Antimicrob.Agents Chemother. 43, 1317\u20131323 (1999).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR16","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/AAC.43.6.1497","volume":"43","author":"M. Heep","year":"1999","unstructured":"Heep M., Beck D., Bayerdoerffer E., Lehn N.: Rifamin and rifabutin resistance mechanism inHelicobacter pylori.Autimicrob. Agens Chemother. 43, 1497\u20131499 (1999).","journal-title":"Autimicrob. Agens Chemother."},{"key":"BF02931577_CR17","first-page":"8","volume":"1","author":"J.G. Hengstler","year":"2002","unstructured":"Hengstler J.G., Heimerdinger C.K., Schiffer I.B., Gebhard S., Segem\u00fcller J., Tanner B., Bolt H.M., Oesch F.: Dietary topoisomerase II-posisons: contribution of soy products to infant leukemia?EXLIJ. 1, 8\u201314 (2002).","journal-title":"EXLIJ."},{"key":"BF02931577_CR18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/AAC.43.7.1693","volume":"43","author":"J.J. Hillard","year":"1999","unstructured":"Hillard J.J., Goldschmidt R.M., Licata L., Baum E.Z., Bush K.: Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.Antimicrob.Agents Chemother. 43, 1693\u20131699 (1999).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/JB.72.4.561-567.1956","volume":"218","author":"H.E. Hopps","year":"1956","unstructured":"Hopps H.E., Wissemann C.L. Jr., Smadel J.E., Ho R.: Mode of action of chloramphenicol \u2014 IV.J.Bacteriol. 218, 561\u2013567 (1956).","journal-title":"J.Bacteriol."},{"key":"BF02931577_CR20","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1073\/pnas.97.12.6775","volume":"97","author":"S. Jin","year":"2000","unstructured":"Jin S., Gorfajn G., Faircloth G., Scotto W.: Ecteinascidin 743, a transcription-target chemotherapeutic that inhibits MDR1 activation.Proc.Nat.Acad.Sci.USA 97, 6775\u20136779 (2000).","journal-title":"Proc.Nat.Acad.Sci.USA"},{"key":"BF02931577_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7164\/antibiotics.48.211","volume":"48","author":"S.-Z. Kagawa","year":"1995","unstructured":"Kagawa S.-Z., Yamashita Y., Ochiai K., Ando K., Iwasaki T., Tokiguschi T., Nakano H.: Terpentecin and UTC4B, new family of topoisomerase II targeting, antitumor antibiotic produced byStreptomyces: producing organism, fermentation and large scale purification.J.Antibiot. 48, 211\u2013216 (1995).","journal-title":"J.Antibiot."},{"key":"BF02931577_CR22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1128\/AAC.46.6.1785-1792.2002","volume":"46","author":"S.I. Khan","year":"2002","unstructured":"Khan S.I., Nimrod A.S., Mehropooya M., Nitiss J.L., Walker L.A., Clarl A.M.: Antifungal activity of eupolarine and its action on AND topoisomerases.Antimicrob.Agents Chemother. 46, 1785\u20131792 (2002).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR23","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1073\/pnas.95.14.8026","volume":"95","author":"H. Kim","year":"1998","unstructured":"Kim H., Xia D., Yu C.-A., Xia J.-Z., Kachurin A.M., Zhang L., Yu L., Deisenhofer J.: Inhibitor binding changes domain mobility in the iron\u2014sulfur protein of the mitochondrialbc 1 complex from bovine heart.Proc.Nat.Acad.Sci.USA 95, 8026\u20138033 (1998).","journal-title":"Proc.Nat.Acad.Sci.USA"},{"key":"BF02931577_CR24","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1128\/AAC.44.12.3249-3256.2000","volume":"44","author":"L.P. Kotra","year":"2000","unstructured":"Kotra L.P., Haddad J., Mobshery S.: Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.Antimicrob.Agents Chemother. 44, 3249\u20133256 (2000).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR25","first-page":"272","volume":"7","author":"Sang-Yong Lee","year":"1997","unstructured":"Lee, Sang-Yong, Hang-Sub Kim, Young-Ho Kim, Sang-Bae Han, Hwan-Mook Kim, Soon-Duck Hong, Jung-Joon Lee: Immunosuppressive activity of elaiophylins.J.Microbiol.Bioctechnol. 7, 272\u2013277 (1997a).","journal-title":"J.Microbiol.Bioctechnol."},{"key":"BF02931577_CR26","first-page":"278","volume":"7","author":"Sang-Yong Lee","year":"1997","unstructured":"Lee, Sang-Yong, Sang-Chul Ha, Young-Soo Hong, Soon-Duck Hong, Jung-Joon Lee: Production of elaiophylin by the strain MCY-846 in a submerged culture.J.Microbiol.Biotechnol. 7, 278\u2013281 (1997b).","journal-title":"J.Microbiol.Biotechnol."},{"key":"BF02931577_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-7506-9095-9.50024-1","volume-title":"Genetics and Biochemistry of Antibiotic Production","author":"D.J. MacNeil","year":"1995","unstructured":"MacNeil D.J.: Avermectins, pp. 421\u2013442 in L.C. Vining, C. Stuttard (Eds):Genetics and Biochemistry of Antibiotic Production. Butterword\u2014Heinemann, Boston 1995."},{"key":"BF02931577_CR28","volume-title":"Medical Microbiology","author":"P.R. Murray","year":"2005","unstructured":"Murray P.R., Pfaller M.A., Rosenthal K.S.:Medical Microbiology, 5th. ed. ASM Press, Washington (DC) 2005.","edition":"5th. ed"},{"key":"BF02931577_CR29","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1128\/AAC.45.5.1522-1527.2001","volume":"45","author":"K. Nagata","year":"2001","unstructured":"Nagata K., Sone N., Tamura T.: Inhibitory activities of lansoprazole against respiration inHelicobacter pylori.Antimicrob.Agents Chemother. 45, 1522\u20131527 (2001).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.bi.60.070191.001203","volume":"60","author":"H.F. Noller","year":"1991","unstructured":"Noller H.F.: Ribosomal RNA and translation.Ann.Rev.Biochem. 60, 191\u2013227 (1991).","journal-title":"Ann.Rev.Biochem."},{"key":"BF02931577_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7164\/antibiotics.51.261","volume":"51","author":"H. Ogawa","year":"1998","unstructured":"Ogawa H., Yamashida Y., Katahira R., Chiba S., Iwasaki T., Shizawa T., Nakano H.: UCG9, a new antitumor antibiotic produced byStreptomyces. I. Producing organism, fermentation, isolation and biological activities.J.Antibiot. 51, 261\u2013266 (1998).","journal-title":"J.Antibiot."},{"key":"BF02931577_CR32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7164\/antibiotics.48.535","volume":"48","author":"S. Omura","year":"1995","unstructured":"Omura S., Sasaki Y., Iwai Y., Takeshima H.: Staurosporin, a potentially important gift from microorganisms.J.Antibiot. 48, 535\u2013545 (1995).","journal-title":"J.Antibiot."},{"key":"BF02931577_CR33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/47.3.261","volume":"47","author":"L.V. Piddock","year":"2001","unstructured":"Piddock L.V., Jin Y.F., Griggs J.: Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones byStaphylococcus aureus.J.Antimicrob.Chemother. 47, 261\u2013270 (2001).","journal-title":"J.Antimicrob.Chemother."},{"key":"BF02931577_CR34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.47.3.837-846.2003","volume":"47","author":"S. Rohrer","year":"2003","unstructured":"Rohrer S., Berger-Baechi B.: FemABX peptidyl transferase: a link between branched-chain cell wall peptide formation and \u03b2-lactam resistance in Gram-positive cocci.Antimicrob.Agents Chemother. 47, 837\u2013846 (2003).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/03009749209101478","volume":"95","author":"R.G. Russell","year":"1992","unstructured":"Russell R.G., Graveley R., Coxon F., Skjdt H., Del Pozo E., Elford P., Mackenzie A.: Cyclosporine A. Mode of action and effects on bone and joint tissues.Scand.J.Rheumatol. 95 (Suppl.), 9\u201318 (1992).","journal-title":"Scand.J.Rheumatol."},{"key":"BF02931577_CR36","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0006-291X(05)80921-0","volume":"173","author":"N. Sato","year":"1990","unstructured":"Sato N., Yusa K., Naito M., Tsuruo T.: Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrugresistant cells.Biochem.Biophys.Res.Commun. 173, 1252\u20131257 (1990).","journal-title":"Biochem.Biophys.Res.Commun."},{"key":"BF02931577_CR37","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1073\/pnas.162522099","volume":"99","author":"J.-H. Shim","year":"2002","unstructured":"Shim J.-H., Lee H.-K., Chang E.-J., Chae W.-J., Han D.-J., Morio T., Yang J.-J., Bothwell A., Lee S.-K.: Immunosuppressive effects of tautomycetinin vivo andin vitro via T cell-specific apoptosis induction.Proc.Nat.Acad.Sci.USA 99, 10617\u201310620 (2002).","journal-title":"Proc.Nat.Acad.Sci.USA"},{"key":"BF02931577_CR38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.7164\/antibiotics.51.991","volume":"51","author":"K. Suzuki","year":"1998","unstructured":"Suzuki K., Nagao K., Monnai Y., Yagi A., Uyeda M.: Topostatin, a novel inhibitor of topoisomerase I and II produced byThermomonospora alba strain no. 1520.J.Antibiot. 51, 991\u2013998 (1998).","journal-title":"J.Antibiot."},{"key":"BF02931577_CR39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.7164\/antibiotics.51.991","volume":"51","author":"K. Suzuki","year":"1998","unstructured":"Suzuki K., Yamaizumi M., Tateishi S., Monnai Y., Yueda M.: Topostatin, a novel inhibitor of topoisomerase I and II produced byThermomonspora alba strain no. 1520.J.Antibiot. 51, 991\u2013998 (1998).","journal-title":"J.Antibiot."},{"key":"BF02931577_CR40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7164\/antibiotics.52.460","volume":"52","author":"K. Suzuki","year":"1999","unstructured":"Suzuki K., Yamaizumi M., Tateishi S., Monnai Y., Uyeda M.: Topostatin, a novel inhibitor of topoisomerases I and II produced byThermomonspora alba strain no. 1520. III. Inhibitory properties.J.Antibiot. 52, 460\u2013465 (1999).","journal-title":"J.Antibiot."},{"key":"BF02931577_CR41","first-page":"1035","volume":"41","author":"M. Uyeda","year":"1998","unstructured":"Uyeda M., Yokomizo K., Miyanoto Y., Habid E.-S.E.: Fattiviracin A1, a novel antiherpetic agent produced byStreptomyces microflavus strain no. 2445. II. Biological properties.J.Amtibiot 41, 1035\u20131039 (1998).","journal-title":"J.Amtibiot"},{"key":"BF02931577_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","volume":"45","author":"B. Vester","year":"2001","unstructured":"Vester B., Douthwaite S.: Macrolide resistance conferred by base substitution in 23S rRNA.Antimicrob.Agents Chemother. 45, 1\u201312 (2001).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931577_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1073\/pnas.120159197","volume":"97","author":"J. Wijnholds","year":"2000","unstructured":"Wijnholds J., Mol C.A.A.M., Van Demeter L., Dehaas M., Scheffer G.L., Baas F., Beijnen J.H., Scheper R.J., Hatse S., De Clercq E., Balzarini J., Borst P.: Multidrug-resistance protein 5 is a multispecific anion transporter able to transport nucleotide analogs.Proc.Nat.Acad.Sci.USA 97, 74\u201376 (2000).","journal-title":"Proc.Nat.Acad.Sci.USA"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02931577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02931577\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02931577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T14:45:43Z","timestamp":1588862743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02931577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["BF02931577"],"URL":"https:\/\/doi.org\/10.1007\/bf02931577","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}